Globus Medical (GMED) PT Raised to $85 at BTIG

Go back to Globus Medical (GMED) PT Raised to $85 at BTIG

Globus Medical (GMED) PT Raised to $100 at Northland Capital Markets

August 5, 2021 7:36 AM EDT

Northland Capital Markets analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 while maintaining an Outperform rating.

The analyst commented, "GMED reported record revenues in 2Q21 of $251.0 million, up 68.6% y/y (up 67.9% cc y/y), easily beating consensus of... More

Globus Medical (GMED) PT Raised to $89 at Truist Securities

August 5, 2021 6:29 AM EDT

Truist Securities analyst Samuel Brodovsky raised the price target on Globus Medical (NYSE: GMED) to $89.00 (from $82.00) while maintaining a Buy rating.

The analyst commented, "GMED announced 2Q results that saw revenue comfortably beat the Street. Guidance was raised on both... More